Lv11
30 积分 2024-01-21 加入
Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma
5小时前
待确认
Enhancer of Zeste Homolog 2 Inhibitor SHR2554 in Relapsed or Refractory Peripheral T-cell Lymphoma: Data from the First-in-Human Phase I Study
2天前
已完结
Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population
2天前
已关闭
Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population
2天前
已关闭
Clinical Characteristic and Survival Outcome of Peripheral T Cell Lymphoma in a Chinese Population
2天前
已关闭
Brentuximab vedotin plus nivolumab after autologous haematopoietic stem-cell transplantation for adult patients with high-risk classic Hodgkin lymphoma: a multicentre, phase 2 trial
8天前
已完结
Bruton Tyrosine Kinase Inhibition: an Effective Strategy to Manage Waldenström Macroglobulinemia
9天前
已完结
Treatment of Hodgkin lymphoma: the past, present, and future
16天前
已完结
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
1个月前
已关闭
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study
1个月前
已关闭
皖公网安备34019202002308
